Brief: Addex Therapeutics Q2 Operating Income CHF -645 Thousand
28/09/2026 06:01
BRIEF-Addex Therapeutics Q2 Operating Income CHF -645 Thousand Sep 28 (Reuters) - Addex Therapeutics Q2 EPS CHF -0.01.
- Q2 net income CHF -1.745 million
Recent news on Addex Therapeutics
See all newsBrief: Addex Spin-Out Neurosterix Completes Phase 1 Clinical Studies Of NTX-253 For Schizophrenia
NASDAQ RESUMED AT 11:29 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:24 AM
Switzerland's Addex Therapeutics Q2 net loss narrows on decline in R&D expenses
Brief: Addex Therapeutics Q2 Operating Income CHF -645 Thousand